Evidence map›Paper›PMID 29942050›Full record

ArticleScientific reports2018

Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases.

Vesna Degoricija, Matias Trbušić, Ines Potočnjak, Bojana Radulović, Sanda Dokoza Terešak, Gudrun Pregartner, Andrea Berghold, Beate Tiran, Saša Frank

Erratum issuedAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. HDL subclasses and mortality in acute heart failure patients.Clinica chimica acta; international journal of clinical chemistry · 2019
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Vesna DegoricijaUniversity of Zagreb School of Medicine, Šalata 3, 10000, Zagreb, Croatia.
Matias TrbušićUniversity of Zagreb School of Medicine, Šalata 3, 10000, Zagreb, Croatia.
Ines PotočnjakUniversity Hospital Centre Sisters of Charity, Department of Medicine, Vinogradska cesta 29, 10000, Zagreb, Croatia.
Bojana RadulovićUniversity Hospital Centre Zagreb, Kišpatićeva 12, 10000, Zagreb, Croatia.
Sanda Dokoza TerešakUniversity Hospital Centre Sisters of Charity, Department of Medicine, Vinogradska cesta 29, 10000, Zagreb, Croatia.
Gudrun PregartnerInstitute for Medical Informatics, Statistics und Documentation, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.
Andrea BergholdInstitute for Medical Informatics, Statistics und Documentation, Medical University of Graz, Auenbruggerplatz 2, 8036, Graz, Austria.
Beate TiranClinical Institute for Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
Saša FrankGottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Molecular Biology and Biochemistry, Medical University of Graz, Neue Stiftingtalstraße 6/6, 8010, Graz, Austria. sasa.frank@medunigraz.at.

Funding

Austrian Science Fund FWF P 27166Austrian Science Fund (FWF Der Wissenschaftsfonds) P27166-B23Oesterreichische Nationalbank (Austrian National Bank) 15858
6 · The paper itself

Abstract

Acute heart failure (AHF) emerges either de novo or from worsening of chronic heart failure (CHF). The aim of the present study was to evaluate the association between worsening of CHF and mortality in AHF patients. Out of 152 included AHF patients, 47 (30.9%) were de novo AHF patients and 105 (69%) were AHF patients with worsening of CHF. The proportion dying in hospital (19.0% vs. 4.3%, p = 0.023) and within 3 months after hospitalization (36.6% vs. 6.7%, p < 0.001) was significantly higher in AHF patients with worsening of CHF. Logistic regression analyses also showed a significant positive association of AHF emerging as worsening of CHF with hospital mortality [odds ratio (OR) and 95% confidence interval (CI): 5.29 (1.46-34.10), p = 0.029] and 3-month mortality [8.09 (2.70-35.03), p = 0.001]. While the association with hospital mortality was no longer significant after adjusting for comorbidities and clinical as well as laboratory parameters known to be associated with mortality in heart failure patients, the association with 3-month mortality remained significant. We conclude that compared to de novo AHF, AHF evolved from worsening of CHF is a more severe condition and is associated with increased mortality.

Indexed as

Hospital MortalityAcute DiseaseAgedAged, 80 and overChronic DiseaseClinical Laboratory TechniquesDisease ProgressionFemaleHeart FailureHumansMaleMiddle Aged

Identifiers

PMID29942050
PMCPMC6018547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.